Mayo Clinic Center for Regenerative Medicine consultant and Biotrust collaborator Dr. Nathan Staff M.D., Ph.D., Assistant Professor of Neurology, has been awarded the Regenerative Medicine Minnesota (RMM) research grant titled "A Phase IIA study using intrathecal treatment of autologous adipose-derived mesenchymal stem cells for amyotrophic lateral sclerosis."
Regenerative Medicine Minnesota aims to improve the health of Minnesotans by advancing regenerative medicine research, education, industry and health care delivery to patients, thereby moving Minnesota to the forefront of regenerative medicine science and practice. Co-chaired by the University of Minnesota and the Mayo Clinic, with community experts in the fields of patient advocacy, industry and business development, one goal of RMM is to keep Minnesotans updated as to how taxpayer dollars are being used to advance regenerative medicine research and treatment in Minnesota. Dr. Staff has been invited to interview with RMM regarding his research efforts, focusing on ALS, the use of mesenchymal stem cells as a therapy, and how the RMM research grant will aid his research moving forward. Congratulations Dr. Staff!